Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
AngioDynamics, Inc. ANGO
$9.15
-$0.12 (-1.29%)
На 18:00, 12 мая 2023
+140.44%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
363555789.00000000
-
week52high
24.74
-
week52low
8.18
-
Revenue
316219000
-
P/E TTM
-9
-
Beta
0.61453200
-
EPS
-0.98000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 июл 2023 г. в 12:30
Описание компании
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Raymond James | Strong Buy | Strong Buy | 13 июл 2022 г. |
| Canaccord Genuity | Buy | Hold | 15 окт 2021 г. |
| Oppenheimer | Perform | 20 авг 2021 г. | |
| Canaccord Genuity | Hold | Hold | 14 июл 2021 г. |
| Raymond James | Strong Buy | Strong Buy | 09 июл 2021 г. |
| Raymond James | Strong Buy | Strong Buy | 07 окт 2022 г. |
| Raymond James | Strong Buy | Strong Buy | 06 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Helsel Dave | D | 19189 | 4633 | 31 янв 2023 г. |
| Trowbridge Stephen A | A | 89581 | 1083 | 12 окт 2022 г. |
| Clemmer James C | A | 450407 | 10000 | 10 окт 2022 г. |
| Helsel Dave | D | 23822 | 5000 | 29 июл 2022 г. |
| Clemmer James C | A | 77530 | 77530 | 20 июл 2022 г. |
| Clemmer James C | A | 66187 | 66187 | 20 июл 2022 г. |
| Clemmer James C | A | 440407 | 33094 | 20 июл 2022 г. |
| Campbell Chad Thomas | A | 9341 | 9341 | 20 июл 2022 г. |
| Campbell Chad Thomas | A | 7974 | 7974 | 20 июл 2022 г. |
| Campbell Chad Thomas | A | 37754 | 3987 | 20 июл 2022 г. |
Новостная лента
Top 5 Health Care Stocks That Are Preparing To Pump In Q2 - AngioDynamics (NASDAQ:ANGO), Apollomics (NASDAQ:APLM)
Benzinga
26 апр 2023 г. в 07:45
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
4 Toxic Stocks That Are Detrimental to Your Portfolio's Health
Zacks Investment Research
14 апр 2023 г. в 10:39
Accurately identifying toxic stocks and getting rid of them at the right time can protect your portfolio. You should sell ANGO, DH, CWST and EVA.
Wall Street Thinks This Small-Cap Stock Can Double in Value
The Motley Fool
04 апр 2023 г. в 09:53
AngioDynamics' sales rose in its latest quarter. The medical device maker's financial health is solid.
AngioDynamics (ANGO) Q3 Earnings Lag Estimates, FY23 View Cut
Zacks Investment Research
31 мар 2023 г. в 21:24
AngioDynamics (ANGO) registers strong revenue growth in the Med Tech and Med Device businesses in third-quarter fiscal 2023.
AngioDynamics (ANGO) Reports Q3 Loss, Lags Revenue Estimates
Zacks Investment Research
30 мар 2023 г. в 09:54
AngioDynamics (ANGO) delivered earnings and revenue surprises of -200% and 2.28%, respectively, for the quarter ended February 2023. Do the numbers hold clues to what lies ahead for the stock?